M&A deals are expanding worldwide. Here’s how to play it.
Retrophin’s promising drug pipeline could boost shares.
Insulated from the dollar, mid-cap companies are thriving.
The mighty dollar is taking its toll on corporate earnings.
Here’s why the US and Hong Kong markets are highly correlated.
In The Money
- 10 key things about social security [kiplinger.com]
- Findings gains as profits stall [online.barrons.com]
- What retirement haven is for you? [reuters.com]
- 6 smart ways to spend $10K [kiplinger.com]
- Greek worries over euro exit [marketwatch.com]
- Beware of dividend stocks [bloomberg.com]
- Keeping your portfolio on track [wsj.com]
- 4 market mistakes to avoid [online.wsj.com]
By clicking any of the links in this section you acknowledge you are leaving Covestor.com. In the Money contains general financial news and is not investment advice. We do not monitor third party web sites, and take no responsibility for any information found therein.
The Latest From
Job growth is slow and the manufacturing sector isn’t expanding.
The Fed may need to factor in jobs growth into monetary policy plans.
First quarter earnings are shaping up to be the weakest since 2009.
Rebounding consumer spending trumps the strong dollar.